This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Liposomal drugs offer targeted cancer treatment promise
Robert Zackin, given three months to live, now cycles to work two years later thanks to Daunosome, a fat bubble drug targeting Kaposi's sarcoma. FDA advisers favor approving Daunosome and Dox SL, signaling a new delivery system that may reduce side effects, though effectiveness across cancers remains unproven.
MENTIONED IN THIS ARTICLE
Washington
Robert Zackin
Boston
Michael Ross
Nexstar Pharmaceuticals Inc
Daunosome
Zackin
Kaposi
Food and Drug Administration
Liposome Technology Inc
FDA
Teresa Wu
Lorraine Cazenave
National Cancer Institute
Nexstar
Ross